Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionRussell Investments Group, Ltd.
Latest Disclosed Ownership234,265 shares
Latest Disclosed Value $ 6,960,031
Russell Investments Group, Ltd. reports 17.89% decrease in ownership of TVTX / Travere Therapeutics, Inc.

On May 8, 2026 - Russell Investments Group, Ltd. filed a 13F-HR form disclosing ownership of 234,265 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $6,960,013 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 285,311 shares of Travere Therapeutics, Inc.. This represents a change in shares of -17.89% during the quarter. The current value of the position is $10,588,778 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 234,265 -51,046 -17.89 6,960 -36.15 0.0075
2026-02-17 2025-12-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 285,311 63,054 28.37 10,902 105.25 0.0119
2025-11-13 2025-09-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 222,257 -15,463 -6.50 5,312 50.97 0.0060
2025-08-13 2025-06-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 237,720 12,784 5.68 3,518 -12.70 0.0045
2025-05-13 2025-03-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 224,936 59,007 35.56 4,031 39.45 0.0055
2025-02-13 2024-12-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 165,929 4,663 2.89 2,890 28.10 0.0040
2024-11-13 2024-09-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 161,266 -4,791 -2.89 2,256 65.40 0.0033
2024-08-08 2024-06-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 166,057 -18,566 -10.06 1,365 -4.15 0.0022
2024-05-08 2024-03-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 184,623 81,611 79.22 1,423 53.67 0.0022
2024-02-05 2023-12-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 103,012 5,499 5.64 926 6.31 0.0016
2023-11-13 2023-09-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 97,513 771 0.80 872 -41.35 0.0017
2023-08-10 2023-06-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 96,742 781 0.81 1,486 -31.19 0.0029
2023-05-09 2023-03-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 95,961 42,756 80.36 2,158 93.02 0.0042
2023-02-08 2022-12-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 53,205 22,209 71.65 1,119 46.72 0.0023
2022-11-04 2022-09-30 13F Travere Therapeutics Common Stock 89422G107 30,996 -12,580 -28.87 762 -27.70 0.0017
2022-07-29 2022-06-30 13F Travere Therapeutics Common Stock 89422G107 43,576 -4,568 -9.49 1,054 -14.86 0.0022
2022-05-05 2022-03-31 13F Travere Therapeutics Common Stock 89422G107 48,144 -19,137 -28.44 1,238 -40.68 0.0022
2022-01-21 2021-12-31 13F Travere Therapeutics Common Stock 89422G107 67,281 -18,575 -21.64 2,087 0.34 0.0033
2021-11-08 2021-09-30 13F Travere Therapeutics Common Stock 89422G107 85,856 -14,787 -14.69 2,080 41.88 0.0035
2021-08-04 2021-06-30 13F Travere Therapeutics Common Stock 89422G107 100,643 -57,832 -36.49 1,466 -62.94 0.0025
2021-05-10 2021-03-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 158,475 158,475 3,956 0.0070
2021-02-08 2020-12-31 13F Retrophin Common Stock 761299106 0 -131,076 -100.00 0 -100.00
2020-11-09 2020-09-30 13F Retrophin Common Stock 761299106 131,076 -18,155 -12.17 2,419 -20.48 0.0052
2020-08-05 2020-06-30 13F RETROPHIN Common Stock 761299106 149,231 41,914 39.06 3,042 94.50 0.0068
2020-05-06 2020-03-31 13F/A-1 Retrophin Common Stock 761299106 107,317 24,871 30.17 1,564 33.68 0.0041
2020-05-06 2020-03-31 13F Retrophin Common Stock 761299106 107,317 24,871 1,564 854.1946
2020-01-29 2019-12-31 13F Retrophin Common Stock 761299106 82,446 57,746 233.79 1,170 309.09 0.0022
2019-11-01 2019-09-30 13F Retrophin Common Stock 761299106 24,700 13,355 117.72 286 25.99 0.0006
2019-08-09 2019-06-30 13F Retrophin Common Stock 761299106 11,345 -230,896 -95.32 227 -95.86 0.0004
2019-05-13 2019-03-31 13F Retrophin Common Stock 761299106 242,241 12,860 5.61 5,484 5.71 0.0101
2019-02-11 2018-12-31 13F Retrophin Common Stock 761299106 229,381 -4,146 -1.78 5,188 -22.64 0.0116
2018-10-26 2018-09-30 13F Retrophin Common Stock 761299106 233,527 34,150 17.13 6,706 23.68 0.0127
2018-08-08 2018-06-30 13F Retrophin Common Stock 761299106 199,377 186,932 1,502.07 5,422 1,843.37 0.0113
2018-05-11 2018-03-31 13F RETROPHIN INC COM Common Stocks 761299106 12,445 -2,591 -17.23 279 -14.42 0.0005
2018-02-06 2017-12-31 13F RETROPHIN INC COM Common Stocks 761299106 15,036 7,637 103.22 326 77.17 0.0005
2017-11-07 2017-09-30 13F RETROPHIN INC COM Common Stocks 761299106 7,399 -670 -8.30 184 17.20 0.0003
2017-07-25 2017-06-30 13F RETROPHIN INC COM Common Stocks 761299106 8,069 -5,865 -42.09 157 -38.91 0.0003
2017-04-26 2017-03-31 13F RETROPHIN INC COM Common Stocks 761299106 13,934 -6,195 -30.78 257 -33.59 0.0005
2017-01-23 2016-12-31 13F RETROPHIN INC COM Common Stocks 761299106 20,129 20,129 387 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.